نتایج جستجو برای: poor asthma treatment

تعداد نتایج: 1632622  

Background: Asthma is one of the most common chronic diseases and may cause psychiatric disorders affecting the patients’ quality of life. In our study, we evaluated the effect of omalizumab treatment on anxiety disorder and depression using Beck Depression Scale (BDS) and State Trait Anxiety Inventory (STAI). Methods: Anxiety level was determined with STAI, whereas depression level was ...

Journal: :Chest 2003
Don D Sin Larry W Svenson Robert L Cowie S F Paul Man

STUDY OBJECTIVE Children from poor families are much more likely to have emergency visits for asthma than those from nonpoor families, which may be related to financial access barriers to good preventive care for the poor. We sought to determine whether in a health-care system that provides free access to outpatient and hospital services, the disparities in the rates of emergency visits for ast...

Journal: :iranian journal of allergy, asthma and immunology 0
mohammad hossein rahimi rad mohammad esmail hejazi

the prevalence of asthma remains difficult to determine with precision with no absolute or gold standard for diagnosis. international study of asthma and allergies in childhood (isaac) developed video questionnaire for epidemiological studies with less reliance on understanding written asthma questionnaire. the aim of this research was to determine the agreement between the isaac written and vi...

Journal: :The Medical journal of Australia 2004
Dianne P Goeman Rosalie A Aroni Susan M Sawyer Kay Stewart Francis C K Thien Michael J Abramson Jo A Douglass

OBJECTIVE To explore the reasons why individuals recurrently present with asthma to hospital emergency departments. DESIGN A predominantly qualitative study in which participants were interviewed in-depth about their asthma. Data on medication use, respiratory health and asthma knowledge were also collected, and asthma severity was determined from medical records. SETTING A tertiary teachin...

Journal: :The Journal of asthma : official journal of the Association for the Care of Asthma 2011
Paul Posadzki Edzard Ernst

OBJECTIVE The objective of this systematic review was to assess the effectiveness of yoga as a treatment option for asthma. METHOD Seven databases were searched from their inception to October 2010. Randomized clinical trials (RCTs) and non-randomized clinical trials (NRCTs) were considered, if they investigated any type of yoga in patients with asthma. The selection of studies, data extracti...

2016
Martin Holmes

Asthma and chronic obstructive pulmonary disease (COPD) are two of the most prevalent chronic respiratory disorders. Over 800 million people suffer from these diseases and over four million people die annually. Although both asthma and COPD are incurable, symptoms can be effectively controlled through the delivery of medication to the lungs. Inhaler devices are employed to deliver medication to...

Journal: :Hong Kong medical journal = Xianggang yi xue za zhi 2005
A M Li T W T Tsang D F Y Chan R Y T Sung T F Fok

Asthma is characterised by variable degrees of airway obstruction, airway hyper-responsiveness, and chronic airway inflammation. Current guidelines emphasise that inhaled corticosteroid treatment is the mainstay of asthma therapy because it targets the underlying airway inflammation. It is prudent to use the lowest possible dose of inhaled corticosteroid compatible with good asthma control. In ...

Journal: :The European respiratory journal 1998
D M Geddes

The article by SZEFLER and LEUNG [1] on corticosteroid-resistant asthma is a useful and thorough review of a difficult topic. I am, however, concerned that three different conditions are becoming confused and this could have important implications for therapy. These conditions are: 1) difficult to control asthma; 2) corticosteroidresistant asthma; 3) other respiratory disease incorrectly diagno...

Journal: :Annals of Allergy Asthma & Immunology 2021

BackgroundPatients with severe, uncontrolled asthma experience frequent exacerbations and hospitalization, leading to poor health-related quality of life. In the phase 2b PATHWAY study (NCT02054130), tezepelumab reduced by up 71% improved lung function, control, life vs placebo.ObjectiveThis analysis further assessed impact on patient-reported outcomes (PROs) in PATHWAY.MethodsAdults were rando...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید